Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.05
-0.0200-1.87%
Post-market: 1.060.0111+1.06%17:20 EDT
Volume:1.10M
Turnover:1.17M
Market Cap:130.20M
PE:-1.56
High:1.08
Open:1.07
Low:1.05
Close:1.07
52wk High:3.06
52wk Low:1.00
Shares:124.00M
Float Shares:106.47M
Volume Ratio:0.74
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6748
EPS(LYR):-0.7517
ROE:-35522.62%
ROA:-42.78%
PB:7.15
PE(LYR):-1.40

Loading ...

Milestone Pharmaceuticals Q2 FY26 Net Loss Widens 120.7% to $28.61 Million

Reuters
·
Aug 12

Milestone Pharmaceuticals Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $559.000K Miss $816.667K Estimate

Benzinga Earnings
·
Aug 12

Milestone Pharmaceuticals Inc Expected to Post a Loss of 19 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Milestone Pharmaceuticals Schedules Q2 Financial Results Call and Business Update

Reuters
·
Aug 05

Analysts’ Top Healthcare Picks: AgomAb Therapeutics NV ADR (AGMB), Milestone Pharmaceuticals (MIST)

TIPRANKS
·
Jul 23

Milestone Pharma Grants 288,000 Inducement Stock Options at $1.32/share

Reuters
·
Jul 03

Milestone Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 03

Alpha Cognition elects Robert Wills as board chairman

Reuters
·
Jun 23

Avalyn Pharma completes target enrollment in MIST trial

TIPRANKS
·
Jun 17

Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis

GlobeNewswire
·
Jun 17

Milestone Pharmaceuticals shareholders approve 6.8 million-share increase to 2019 equity plan

Reuters
·
Jun 16

Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)

TIPRANKS
·
May 27

Milestone Pharmaceuticals (MIST) Gets a Buy from Piper Sandler

TIPRANKS
·
May 14

Milestone Pharmaceuticals files $300M mixed securities shelf

TIPRANKS
·
May 14

Milestone Pharmaceuticals Files $300 Million Mixed Shelf

MT Newswires Live
·
May 14

BRIEF-Milestone Pharmaceuticals Inc - May Offer Securities Up To $300 Million - SEC Filing

Reuters
·
May 14

Milestone Pharmaceuticals Inc - May Offer up to $100 Mln Common Shares via Cantor Fitzgerald Sales Agreement - SEC Filing

THOMSON REUTERS
·
May 14

Analyst Reiterates Buy on MIST, Maintains $8 Price Target on Strong CARDAMYST Launch and Expanded AFib Opportunity

TIPRANKS
·
May 14

Milestone Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Milestone Shares Fall on Unexpected 1Q Loss

Dow Jones
·
May 13